What was Allstate's latest EPS?
Allstate reported an EPS of $5.94 for the most recent quarter.
Yanuki
ARTICLE DETAIL
Institutional Investors Adjust Positions in The Allstate Corporation (ALL) | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026 | Institutional Investors Adjust Positions in The Allstate Corporation (ALL) | Is Tesla Stock Going to $1,000? | Why the Nasdaq Is Holding Up Better Amid Geopolitical Tensions | Walmart vs BJ's Wholesale: Which Retailer Is a Better Buy? | Institutional Investors Increase Holdings in Invesco QQQ | ExxonMobil (XOM) Stock Analysis: Retail Investors and Market Trends in 2026 | Warren Buffett's Oil Bet: Analyzing Occidental Petroleum (OXY) and the Energy Market in 2026 | Tesla's Risks and Investment Alternatives | Micron Stock: Supply Tightness and Growth Potential in 2026
Finance / Stocks
Institutional Investors Adjust Positions in The Allstate Corporation (ALL)
Several institutional investors have adjusted their positions in The Allstate Corporation (NYSE:ALL) during the recent quarters. This activity reflects the dynamic investment strategies of major financial players and their outlook on Allsta...
Key Insights
- Triumph Capital Management acquired 2,069 shares of Allstate, valued at approximately $417,000.
- Financiere des Professionnels Fonds d investissement inc. purchased 3,683 shares, worth around $741,000.
- MBB Public Markets I LLC invested $312,000, acquiring 1,507 shares.
- Allstate reported strong EPS of $5.94, surpassing analysts' estimates of $3.20.
- The company declared a $1.00 quarterly dividend, yielding 2.0% annually.
In-Depth Analysis
Allstate's stock has seen considerable activity from institutional investors. Price T Rowe Associates Inc. MD, Boston Partners, GAMMA Investing LLC, Mackenzie Financial Corp, and Goldman Sachs Group Inc. have all increased their positions. These changes reflect a broader sentiment among institutional investors. Allstate (NYSE:ALL - Get Free Report) has a market capitalization of $51.72 billion, a price-to-earnings ratio of 9.23, and a beta of 0.37. The company's strong earnings report, with an EPS of $5.94, surpassed analysts' expectations. Revenue for the quarter was up 5.8% year-over-year. The company also declared a quarterly dividend of $1.00 per share, payable on October 1st, with a record date of August 29th. Several analysts have updated their ratings on Allstate, with UBS Group increasing their price objective to $235.00 and Wall Street Zen upgrading the stock to a "buy" rating.
FAQ
What is Allstate's current dividend yield?
Allstate's current dividend yield is 2.0%.
What is the consensus rating for Allstate stock?
The consensus rating for Allstate stock is "Moderate Buy".
Takeaways
- Monitor institutional investor activity to gauge market sentiment.
- Allstate's strong financial performance and dividend payouts make it an attractive investment.
- Keep an eye on analyst ratings and price targets for potential stock movement.
- Allstate has announced a quarterly dividend of $1.00 per share, set to be paid on October 1st, resulting in an annual yield of 2.0%.
Discussion
Do you think Allstate is a good investment? Share your thoughts in the comments below!
Share this article with others who need to stay ahead of this trend!
Sources
Disclaimer
This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.
All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.
This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.
Always do your own research (DYOR) before making any decisions based on the information presented.